Biltmore Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,370
Closed -$552K 63
2026
Q1
$552K Buy
6,370
+33
+0.5% +$3.16K 0.2% 43
2025
Q4
$609K Sell
6,337
-12
-0.2% -$1.17K 0.23% 39
2025
Q3
$605K Sell
6,349
-103
-2% -$9.47K 0.23% 40
2025
Q2
$562K Sell
6,452
-258
-4% -$21.9K 0.23% 39
2025
Q1
$603K Sell
6,710
-188
-3% -$16.8K 0.25% 35
2024
Q4
$551K Sell
6,898
-27
-0.4% -$2.34K 0.23% 38
2024
Q3
$623K Buy
6,925
+510
+8% +$42.9K 0.26% 39
2024
Q2
$505K Sell
6,415
-669
-9% -$54.8K 0.22% 41
2024
Q1
$584K Hold
7,084
0.28% 39
2023
Q4
$584K Hold
7,084
0.28% 39
2023
Q3
$555K Hold
7,084
0.27% 38
2023
Q2
$624K Buy
7,084
+217
+3% +$18.7K 0.26% 35
2023
Q1
$554K Buy
6,867
+249
+4% +$20.3K 0.22% 36
2022
Q4
$514K Hold
6,618
0.22% 37
2022
Q3
$534K Buy
6,618
+1,310
+25% +$118K 0.25% 34
2022
Q2
$476K Sell
5,308
-62
-1% -$6.28K 0.21% 37
2022
Q1
$596K Buy
5,370
+34
+0.6% +$3.59K 0.23% 37
2021
Q4
$552K Sell
5,336
-765
-13% -$88.6K 0.21% 39
2021
Q3
$765K Buy
6,101
+98
+2% +$12.7K 0.31% 34
2021
Q2
$745K Buy
6,003
+246
+4% +$30.9K 0.3% 31
2021
Q1
$680K Buy
+5,757
New +$675K 0.3% 31

Other funds holding MDT

Biltmore Wealth Management's MDT Position: Q2 2026 in Review

Biltmore Wealth Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 6,370 shares — an estimated $552K sold.

Biltmore Wealth Management first reported a position in MDT in Q1 2021 and held it in 21 quarters. The position peaked at $765K in Q3 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Biltmore Wealth Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Biltmore Wealth Management sold 6,370 Medtronic shares in Q2 2026, an estimated $552K.
  • Biltmore Wealth Management first reported a position in Medtronic in Q1 2021 and held it in 21 quarters.
  • Biltmore Wealth Management's Medtronic position peaked at $765K in Q3 2021.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Biltmore Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.